le 20 mars/March 2019

	The common shares of Cansortium Inc. have been approved for listing on the CSE.

	Listing and disclosure documents will be available at&nbsp;www.thecse.com&nbsp;on the trading date.

	Cansortium Inc. is a market leader in the vertical integration of seed to sale of processed cannabis oil in medical use frameworks in the United States and is developing such framework in other international jurisdictions.&nbsp; The Company operates ongoing physician engagement as well as research and development programs.

	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ________________________

	Les actions ordinaires de Cansortium Inc. ont été approuvées pour être inscrites à la cote de la CST.

	Les documents de cotation et d'information seront disponibles sur www.thecse.com à la date de négociation.

	Cansortium Inc. est un chef de file du marché de l'intégration verticale de la graine à la vente de l'huile de cannabis transformée dans des cadres d'utilisation médicale aux États-Unis et est en train de le développer dans d'autres juridictions internationales. La société exploite un engagement continu des médecins ainsi que des programmes de recherche et développement.
<table border="1" cellpadding="0" cellspacing="1" >
<tbody>
<tr>
<td >

					Issuer/Émetteur:
</td>
<td >

					Cansortium Inc.
</td>
</tr>
<tr>
<td>

					Security Type/Titre:
</td>
<td>

					Common&nbsp;Shares/ Actions ordinaires
</td>
</tr>
<tr>
<td>

					Symbol(s)/Symbole(s):
</td>
<td>

					TIUM.U
</td>
</tr>
<tr>
<td>

					Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:
</td>
<td>

					60 571 801
</td>
</tr>
<tr>
<td>

					Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:(1)
</td>
<td>

					161,874,919
</td>
</tr>
<tr>
<td>

					CSE Sector/Catégorie:
</td>
<td>

					Life Sciences/Sciences biologiques
</td>
</tr>
<tr>
<td>

					CUSIP:
</td>
<td>

					13809L109
</td>
</tr>
<tr>
<td>

					ISIN:
</td>
<td>

					CA13809L1094
</td>
</tr>
<tr>
<td>

					Boardlot/Quotité:
</td>
<td>

					100
</td>
</tr>
<tr>
<td>

					IPO Price/Prix:
</td>
<td>

					$2.00/2,00 $US
</td>
</tr>
<tr>
<td>

					Agent(s)/Agentes:
</td>
<td>

					Paradigm Capital Inc. and Canaccord Genuity Corp.
</td>
</tr>
<tr>
<td>

					Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:
</td>
<td>

					US$/$US
</td>
</tr>
<tr>
<td>

					Listing Date/Date de l’inscription:
</td>
<td>

					le 21 mars/March 2019
</td>
</tr>
<tr>
<td>

					Trading Date/Date de&nbsp;negociation:
</td>
<td>

					le 21 mars/March 2019
</td>
</tr>
<tr>
<td>

					Other Exchanges/Autres&nbsp;marches:
</td>
<td>

					N/A
</td>
</tr>
<tr>
<td>

					Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:
</td>
<td>

					Le 31 décembre/December
</td>
</tr>
<tr>
<td>

					Transfer Agent/Agent des&nbsp;transferts:
</td>
<td>

					Odyssey Trust Company
</td>
</tr>
</tbody>
</table>

	&nbsp;
<table border="1" cellpadding="0" cellspacing="1" >
<tbody>
<tr>
<td >

					Issuer/Émetteur:
</td>
<td>

					Cansortium Inc. - Warrants
</td>
</tr>
<tr>
<td>

					Security Type/Titre:
</td>
<td>

					Warrants
</td>
</tr>
<tr>
<td>

					Listing Date/Date de l’inscription:
</td>
<td>

					le 21 mars/March 2019
</td>
</tr>
<tr>
<td>

					Trading Date/Date de&nbsp;negociation:
</td>
<td>

					le 21 mars/March 2019
</td>
</tr>
<tr>
<td>

					Symbol:
</td>
<td>

					TIUM.WT.U
</td>
</tr>
<tr>
<td>

					Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:
</td>
<td>

					14 044 500
</td>
</tr>
<tr>
<td>

					CUSIP:
</td>
<td>

					13809L133
</td>
</tr>
<tr>
<td>

					ISIN:
</td>
<td>

					CA13809L1334
</td>
</tr>
<tr>
<td>

					Boardlot/Quotité:
</td>
<td>

					100
</td>
</tr>
<tr>
<td>

					Exercise Price/Prix ​​d'exercice:
</td>
<td>

					$2.40/2,40 $US
</td>
</tr>
<tr>
<td>

					Expiry Date/date d'expiration:
</td>
<td>

					Le 21 mars/March 2021
</td>
</tr>
<tr>
<td>

					Transfer Agent/Agent des&nbsp;transferts:
</td>
<td>

					Odyssey Trust Company
</td>
</tr>
</tbody>
</table>

	(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There are 13,164,377 Proportionate Voting Shares issued and outstanding.&nbsp; Each Proportionate Voting Share is convertible into ten Common Shares.&nbsp; This number also includes Common Shares underlying existing convertible securities.

	The Exchange is accepting Market Maker applications for TIUM.U. Please email: <a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	&nbsp;

Cansortium Inc. 

2019-0326 – New Listing - Cansortium Inc. (TIUM.U and TIUM.WT.U)

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.